salesforce.com (CRM): Fears Misplaced - Wedbush

Wedbush analyst, Steve Koenig, reiterated his Outperform rating on shares of salesforce.com (NYSE: CRM) noting that shares have been under pressure since the June news of its acquisition of Demandware and its unsuccessful bidding war with Microsoft for LinkedIn. The buyside appears concerned that Salesforce is trying to sustain its growth in the face of organic sales deceleration. However, the analyst thinks Salesforce’s motivations in both of the deals strategic and he is not seeing any evidence of a secular or cyclical slowdown in Salesforce’s business.

The analyst stated "We think the current entry point for CRM shares looks compelling, given our outlook for a solid 2Q, sustained 20%+ organic growth, attractive trading multiples (26x EV/FCF on CY17E), healthy FCF generation, a strong market position and consistent execution". No change to the price target of $98.

For an analyst ratings summary and ratings history on salesforce.com click here. For more ratings news on salesforce.com click here.

Shares of salesforce.com closed at $77.82 yesterday.

You May Also Be Interested In

• D.A. Davidson Adds Salesforce (CRM) to its Best-of-Breed Bison List
• TE Connectivity (TEL) PT Raised to $150 at Stifel
• Boston Scientific (BSX) PT Raised to $80 at BTIG